Kavolus Joseph J, Sia David, Potter Hollis G, Attarian David E, Lachiewicz Paul F
J. J. Kavolus, D. E. Attarian, P. F. Lachiewicz Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA D. Sia, H. G. Potter, Department of Radiology and Imaging, MRI Research, Hospital for Special Surgery, New York, NY, USA.
Clin Orthop Relat Res. 2018 Jan;476(1):30-36. doi: 10.1007/s11999.0000000000000006.
Surgeon-performed periarticular injections and anesthesiologist-performed femoral nerve or adductor canal blocks with local anesthetic are in common use as part of multimodal pain management regimens for patients undergoing TKA. However, femoral nerve blocks risk causing quadriceps weakness and falls, and anesthesiologist-performed adductor canal blocks are costly in time and resources and may be unreliable. We investigated the feasibility of a surgeon-performed saphenous nerve ("adductor canal") block from within the knee at the time of TKA.
QUESTIONS/PURPOSES: (1) Can the saphenous nerve consistently be identified distally on MRI studies, and is there a consistent relationship between the width of the femoral transepicondylar axis (TEA) and the proximal (cephalad) location where the saphenous nerve emerges from the adductor canal? With these MRI data, we asked the second question: (2) Can we utilize this anatomic relationship to simulate a surgeon-performed intraoperative block of the distal saphenous nerve from within the knee with injections of dyes after implantation of trial TKA components in cadaveric lower extremity specimens?
A retrospective analysis of 94 thigh-knee MRI studies was performed to determine the relationship between the width of the distal femur at the epicondylar axis and the proximal location of the saphenous nerve after its exit from the adductor canal and separation from the superficial femoral artery. These studies, obtained from one hospital's MRI library, had to depict the saphenous nerve in the distal thigh and the femoral epicondyles and excluded patients younger than 18 years of age or with metal implants. These studies were performed to evaluate thigh and knee trauma or unexplained pain, and 55 had some degree of osteoarthritis. After obtaining these data, TKA resections and trial component implantation were performed, using a medial parapatellar approach, in 11 fresh cadaveric lower extremity specimens. There were six male and five female limbs from cadavers with a mean age of 70 years (range, 57-80 years) and mean body mass index of 20 kg/m (range, 15-26 kg/m) without known knee arthritis. Using a blunt-tipped 1.5-cm needle, we injected 10 mL each of two different colored solutions from inside the knee at two different locations and, after 30 minutes, dissected the femoral and saphenous nerves and femoral artery from the hip to the knee. Our endpoints were whether the saphenous nerve was bathed in dye and if the dye or needle was located in the femoral artery or vein.
Based on the MRI analysis, the mean ± SD TEA was 75 ± 4 mm in females and 87 ± 4 mm in males. The saphenous nerve exited the adductor canal and was located at a mean of 1.5 ± 0.16 times the TEA width in females and a mean of 1.3 ± 0.13 times the TEA width in males proximal to the medial epicondyle. After placement of TKA trial components and injection, the proximal injection site solution bathed the saphenous nerve in eight of 11 specimens. In two cachectic female cadaver limbs, the dye was located posteriorly to the nerve in hamstring muscle. The proximal blunt needle and colored solution were directly adjacent to but did not penetrate the femoral artery in only one specimen.
This study indicates, based on MRI measurements, cadaveric injections, and dissections, that a surgeon-performed injection of the saphenous nerve from within the knee after it exits from the adductor canal seems to be a feasible procedure.
This technique may be a useful alternative to an ultrasound-guided block. A trial comparing surgeon- and anesthesiologist-performed nerve block should be considered to determine the clinical efficacy of this procedure.
外科医生进行的关节周围注射以及麻醉医生进行的局部麻醉股神经或收肌管阻滞,是全膝关节置换术(TKA)患者多模式疼痛管理方案的常用组成部分。然而,股神经阻滞有导致股四头肌无力和跌倒的风险,且麻醉医生进行的收肌管阻滞在时间和资源上成本较高,可能并不可靠。我们研究了TKA手术时外科医生在膝关节内进行隐神经(“收肌管”)阻滞的可行性。
问题/目的:(1)在MRI研究中能否始终在远端识别出隐神经,股骨髁间轴(TEA)宽度与隐神经从收肌管穿出的近端(头侧)位置之间是否存在一致的关系?基于这些MRI数据,我们提出了第二个问题:(2)在尸体下肢标本中植入TKA试验组件后,能否利用这种解剖关系,通过注射染料来模拟外科医生在膝关节内对远端隐神经进行术中阻滞?
对94例大腿-膝关节MRI研究进行回顾性分析,以确定股骨髁间轴处远端股骨宽度与隐神经从收肌管穿出并与股浅动脉分离后的近端位置之间的关系。这些研究取自一家医院的MRI库,必须描绘出大腿远端和股骨髁的隐神经,排除年龄小于18岁或有金属植入物的患者。这些研究是为了评估大腿和膝关节创伤或不明原因的疼痛,其中55例有一定程度的骨关节炎。获取这些数据后,在11个新鲜尸体下肢标本中采用内侧髌旁入路进行TKA切除和试验组件植入。尸体的四肢中,6例为男性,5例为女性,平均年龄70岁(范围57 - 80岁),平均体重指数20 kg/m²(范围15 - 26 kg/m²),无已知膝关节关节炎。使用1.5厘米钝头针,在膝关节内两个不同位置分别注射10毫升两种不同颜色的溶液,30分钟后,从髋关节到膝关节解剖股神经、隐神经和股动脉。我们的观察终点是隐神经是否被染料浸润,以及染料或针头是否位于股动脉或静脉内。
基于MRI分析,女性的平均±标准差TEA为75±4毫米,男性为87±4毫米。隐神经从收肌管穿出,在女性中位于距内侧髁近端平均为TEA宽度的1.5±0.16倍处,在男性中为TEA宽度的1.3±0.13倍处。植入TKA试验组件并注射后,11个标本中有8个近端注射部位的溶液浸润了隐神经。在两具消瘦女性尸体的下肢中,染料位于腘绳肌中神经的后方。仅在1个标本中,近端钝针和有色溶液紧邻股动脉但未穿透。
基于MRI测量、尸体注射和解剖,本研究表明,外科医生在隐神经从收肌管穿出后在膝关节内进行注射似乎是一种可行的方法。
该技术可能是超声引导阻滞的一种有用替代方法。应考虑进行一项比较外科医生和麻醉医生进行神经阻滞的试验,以确定该方法的临床疗效。